Bing Xu

13PUBLICATIONS
71CO-AUTHORS
Predictive and prognostic markersHaematological tumoursInnate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 17, 2025
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.

Wenyu Shi, Zijun Y Xu-Monette, Youchao Jia

|May 09, 2025
Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study.

Si-Yuan Chen, Peng-Peng Xu, Ru Feng

|Jan 27, 2025
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.

Ken Young, Wen-Yu Shi, Zijun Xu-Monette

|Mar 28, 2023
Themis suppresses the effector function of CD8+ T cells in acute viral infection.

Jian Tang, Xian Jia, Jian Li

|Jan 23, 2023
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study.

Wei Xu, Keshu Zhou, Tingyu Wang

|Feb 15, 2022
Themis is indispensable for IL-2 and IL-15 signaling in T cells.

Yongchao Liu, Yu Cong, Yujia Niu

Pageof 3

Frequent Collaborators

3 joint publications

Michael Møller

3 joint publications

Andrés J M Ferreri

3 joint publications

Yong Li

3 joint publications

Alexandar Tzankov